CVS Health Corporation (CVS)

pos +0.00
Today's Range: 0.00 - 0.00 | CVS Avg Daily Volume: 0
Last Update: 07/28/15 - 4:01 PM EDT
Volume: 0
YTD Performance: 0.00%
Open: $0.00
Previous Close: $111.64
52 Week Range: $74.69 - $111.91
Oustanding Shares: 1,128,331,000
Market Cap: 125,966,872,800
6-Month Chart
TheStreet Ratings Grade for CVS
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy
Moderate Buy
Moderate Sell
Strong Sell
Mean Rec. 0.00 0.00 0.00 0.00
Latest Dividend: 0.00
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 12/31/69
Price Earnings Ratio: 0.00
Price Earnings Comparisons:
CVS Sector Avg. S&P 500
0.00 0.00 0.00
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
0.00% 0.00% 0.00%
Revenue 0.00 0.00 0.00
Net Income 0.00 0.00 0.00
EPS 0.00 0.00 0.00
Earnings for CVS:
Revenue 0.00B
Average Earnings Estimates
Qtr (06/15) Qtr (09/15) FY (12/15) FY (12/16)
Average Estimate $1.20 $1.37 $5.16 $5.92
Number of Analysts 24 24 25 26
High Estimate $1.22 $1.44 $5.25 $6.19
Low Estimate $1.18 $1.31 $5.09 $5.60
Prior Year $1.13 $1.15 $4.22 $5.16
Growth Rate (Year over Year) 5.90% 18.73% 22.33% 14.68%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
Jul 22, 2015 | 7:18 AM EDT
Shares of CVS now seen reaching $117, according to Deutsche Bank. Estimates also upped, as recent acquisitions should add to earnings. ...
Wal-Mart has also taken great strides, but Target has been more impressive.
Jun 23, 2015 | 6:52 AM EDT
Jefferies Consumer Conference (Day 1 of 2) - 06/23/15 - 06/24/15 Nantucket, MA
Jun 18, 2015 | 7:26 AM EDT
CVS was initiated with an Outperform rating, Oppenheimer said. $119 price target. Focus on health can drive growth. 
It is a win-win for the companies and stocks.
Margins continue to be hurt by incentives and concessions.
Both chains' new CEOs are shaking things up, but TGT is winning.
Take advantage of irrational collateral damage to stocks.
We applaud the deal with CVS Health, which allows Target to focus on its more profitable categories.

Columnist Conversations

I am beginning to replace my sold Twitter in after hours at under $33/share on a scale. As extreme the rise wa...
Good day in market but some of the rises in oil related and industrial names today seem like dead cat bounces....
A big shout out to "Monkey Girl" who I gave Twitter stock to on the occasion of her Bat Mitzvah this year - an...
We're all familiar with the morningstar candle pattern. It is a three day bullish reversal pattern formed by a...


News Breaks

Powered by

Columnist Tweets


Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.